Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Smith & Nephew Advanced Wound Management announces launch of ACTICOAT* Flex
Nov 07, 2008 08:12 AM
- New Acticoat(TM) Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada
Nov 07, 2008 08:02 AM
- New Acticoat(TM) Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada
Nov 07, 2008 08:00 AM
- NUCRYST Announces Third Quarter 2008 Financial Results
Nov 06, 2008 06:59 PM
- NUCRYST Announces Third Quarter 2008 Financial Results
Nov 06, 2008 06:59 PM
- NUCRYST Pharmaceuticals to Release Third Quarter 2008 Financial Results on Thursday, November 6, 2008
Oct 24, 2008 11:20 AM
- NUCRYST Pharmaceuticals to Release Third Quarter 2008 Financial Results on Thursday, November 6, 2008
Oct 24, 2008 11:19 AM
- NUCRYST to Present at Rodman & Renshaw 10th Annual healthcare Conference on November 10, 2008
Oct 21, 2008 11:01 AM
- NUCRYST to Present at Rodman & Renshaw 10th Annual healthcare Conference on November 10, 2008
Oct 21, 2008 11:01 AM
- NUCRYST Receives Nasdaq Deficiency Notice
Oct 03, 2008 06:39 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
NCST
|
Compare to S&P
|
| YTD |
-43.57 %
|
-12.33 %
|
| 4 Weeks |
-19.39 %
|
-10.37 %
|
| 12 Weeks |
-16.84 %
|
32.14 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 100.00 %
|
|
EPS Growth in Last Year: 100.00 %
|
|
Sales Growth in Last Quarter: 11.58 %
|
|
Sales Growth in Last Quarter: -30.19 %
|
|
|
